Literature DB >> 19045957

The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent.

Eric Murillo-Rodríguez1, Diana Millán-Aldaco, Marcela Palomero-Rivero, Raphael Mechoulam, René Drucker-Colín.   

Abstract

Cannabidiol (CBD) is a constituent of Cannabis sativa that induces nonpsychotropic effects, and some of its biological actions in sleep have been described by the authors' group. Here, the authors report that when administered 10 or 20 microg/1 microl during the lights-on period directly into either lateral hypothalamus (LH) or dorsal raphe nuclei (DRN), which are wake-inducing brain areas, CBD enhanced wakefulness and decreased slow wave sleep and REM sleep. Furthermore, CBD increased alpha and theta power spectra but diminished delta power spectra. Additionally, CBD increased c-Fos expression in LH or DRN. These findings suggest that this cannabinoid is a wake-inducing compound that presumably activates neurons in LH and DRN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19045957     DOI: 10.1037/a0013278

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  12 in total

1.  Weighing the balance: how analgesics used in chronic pain influence sleep?

Authors:  Miqdad H Bohra; Chhavi Kaushik; Daniel Temple; Sharon A Chung; Colin M Shapiro
Journal:  Br J Pain       Date:  2014-08

2.  Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.

Authors:  E M Rock; D Bolognini; C L Limebeer; M G Cascio; S Anavi-Goffer; P J Fletcher; R Mechoulam; R G Pertwee; L A Parker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats.

Authors:  Eric Murillo-Rodríguez; Gloria Arankowsky-Sandoval; Nuno Barbosa Rocha; Rodrigo Peniche-Amante; André Barciela Veras; Sérgio Machado; Henning Budde
Journal:  Neurochem Res       Date:  2018-06-06       Impact factor: 3.996

4.  Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence.

Authors:  Eric Murillo-Rodríguez; Diana Millán-Aldaco; Dorotea Cicconcelli; Valentina Giorgetti; Gloria Arankowsky-Sandoval; Jocelyne Alcaraz-Silva; Claudio Imperatori; Sérgio Machado; Henning Budde; Pablo Torterolo
Journal:  Psychopharmacology (Berl)       Date:  2021-02-26       Impact factor: 4.530

5.  Natural Cannabinoids as Templates for Sleep Disturbances Treatments.

Authors:  Eric Murillo-Rodríguez; Sérgio Machado; Claudio Imperatori; Tetsuya Yamamoto; Henning Budde
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Synthetic and Natural Derivatives of Cannabidiol.

Authors:  Paula Morales; Nadine Jagerovic
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.

Authors:  Maureen L Petrunich-Rutherford; Michael W Calik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.

Authors:  Eric Murillo-Rodríguez; Marcela Palomero-Rivero; Diana Millán-Aldaco; Oscar Arias-Carrión; René Drucker-Colín
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

9.  Potential effects of cannabidiol as a wake-promoting agent.

Authors:  Eric Murillo-Rodríguez; Andrea Sarro-Ramírez; Daniel Sánchez; Stephanie Mijangos-Moreno; Alma Tejeda-Padrón; Alwin Poot-Aké; Khalil Guzmán; Elda Pacheco-Pantoja; Oscar Arias-Carrión
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

10.  Role of N-Arachidonoyl-Serotonin (AA-5-HT) in Sleep-Wake Cycle Architecture, Sleep Homeostasis, and Neurotransmitters Regulation.

Authors:  Eric Murillo-Rodríguez; Vincenzo Di Marzo; Sergio Machado; Nuno B Rocha; André B Veras; Geraldo A M Neto; Henning Budde; Oscar Arias-Carrión; Gloria Arankowsky-Sandoval
Journal:  Front Mol Neurosci       Date:  2017-05-30       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.